All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @rahulmodifit on TikTok · 122s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @rahulmodifit's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00The peptides BPC-157 and TB-500 helped me avoid surgery. Back in November of 2023, I was at the
  2. 0:06end of a pretty heavy bulk and I was trying to hit a squat PR of 405 and I was attempting a PR
  3. 0:11every single week. Now I had hit 385 and about a week later I tore my meniscus. Now it didn't
  4. 0:16happen while I was squatting but attempting a PR on squat every single week is definitely not
  5. 0:20good for your joints and it wasn't the smartest thing for me to do. After an ultrasound confirmed
  6. 0:24that I did tear my meniscus, I was pretty bummed out because I thought my training career was pretty
  7. 0:28much over. I wanted to avoid surgery because with meniscus procedures they end up removing more tissue
  8. 0:33and this tissue doesn't grow back. This would have affected me and my joints in the long term and I
  9. 0:37was trying to avoid that. I quickly found myself in a rabbit hole on reddit and without hesitation
  10. 0:42I ordered myself some BPC-157. BPC-157 is composed of 15 amino acids. It works by stimulating angiogenesis,
  11. 0:49boosting nitric oxide and activating fibroblasts, essentially it boosts circulation and improves
  12. 0:55So I ran BPC alone for about 8 weeks and saw a lot of improvement. I didn't feel like it was
  13. 0:59completely done healing so after waiting about another 10 weeks I introduced TB-500. This peptide
  14. 1:05works a little more systemically, reducing inflammation and improving recovery throughout the entire body.
  15. 1:09In late January which was about 3 months after I initially injured my meniscus, I started training
  16. 1:14my legs very lightly. So while I ran BPC-157 and TB-500 for another 10 weeks, I hit a new max
  17. 1:20squad of 405 in April. Granted it probably wasn't the smartest move to go that heavy that fast after
  18. 1:26a meniscus injury but I had been chasing 405 for so long and I just had to get it. The thing with
  19. 1:30meniscus injuries is that they don't fully heal and I still feel a dull sensation at times but the
  20. 1:35peptides have helped me manage that discomfort and stay functional. Of course I started taking
  21. 1:39these peptides for my knee but I've also seen benefits in my shoulder pain on chest day which
  22. 1:44was an added bonus. I still run this peptide blend a couple times a year especially when I'm going
  23. 1:48into a heavy training period. I feel like it's becoming a key part of my routine for managing my
  24. 1:53joint pain and keeping my body healthy. Now I'm not a physician and you should definitely consult a
  25. 1:57medical professional if you're going to take these peptides but this is just my experience so good luck.

Did peptides actually help this creator avoid knee surgery?

Rahul | Weight Loss Coach

TikTok creator

11.3K viewsWatch on TikTok

Quick answer

Rahul describes a confirmed meniscal tear treated with an 18-week self-administered course of BPC-157 and TB-500 sourced outside clinical channels, alongside gradual return-to-training. His reported outcome, reduced pain and return to heavy squatting, cannot be attributed to peptides over conservative management and time given the lack of a control condition. Neither BPC-157 nor TB-500 is FDA-approved for human use, and no published human RCTs exist for either peptide in the context of meniscal injury.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksBPC-157Provider discussion

Evidence signal

Source-backed review

Regulatory reality

BPC-157 access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Did peptides actually help this creator avoid knee surgery?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

BPC-157 is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this bpc-157 video claims cluster

Best for searchers trying to separate BPC-157 research signals from overconfident recovery claims.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Did peptides actually help this creator avoid knee surgery?" from Rahul | Weight Loss Coach. We read the clip as a Peptide social video fact-checks claim about BPC-157, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Rahul describes a confirmed meniscal tear treated with an 18-week self-administered course of BPC-157 and TB-500 sourced outside clinical channels, alongside gradual return-to-training.

The reason this review is not generic is the source wording and the canonical claim label "peptides how peptides helped me avoid knee surgery in late 2023 i hit." In this clip, the useful excerpt is: "The peptides BPC-157 and TB-500 helped me avoid surgery." That wording changes the review because it points to BPC-157 safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Multifunctionality and Possible Medical Application of the BPC 157 Peptide (2025), Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing (2019), and Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025), plus the creator's own wording. BPC-157 still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The only human RCT evidence on meniscal tears and conservative care, Katz et al.
People who land here are usually comparing the BPC-157 claim with [object Object].
The strongest next step is to compare the claim with FormBlends' BPC-157 guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Rahul describes a confirmed meniscal tear treated with an 18-week self-administered course of BPC-157 and TB-500 sourced outside clinical channels, alongside gradual return-to-training.

FormBlends verdict

BPC-157 safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the BPC-157 guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Rahul describes a confirmed meniscal tear treated with an 18-week self-administered course of BPC-157 and TB-500 sourced outside clinical channels, alongside gradual return-to-training. His reported outcome, reduced pain and return to heavy squatting, cannot be attributed to peptides over conservative management and time given the lack of a control condition. Neither BPC-157 nor TB-500 is FDA-approved for human use, and no published human RCTs exist for either peptide in the context of meniscal injury.
  • Neither BPC-157 nor TB-500 is FDA-approved for human use, and both are classified as research chemicals with no guaranteed purity or sterility standards when sourced outside clinical compounding channels.
  • The only human RCT evidence on meniscal tears and conservative care, Katz et al. 2013 in the New England Journal of Medicine, found physical therapy alone comparable to surgery, meaning natural recovery with rehab is a highly plausible explanation for outcomes like Rahul's.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • BPC-157 decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the BPC-157 guide, cost path, safety notes, and provider review before acting.

Review BPC-157

What You'll Learn

  • Neither BPC-157 nor TB-500 is FDA-approved for human use, and both are classified as research chemicals with no guaranteed purity or sterility standards when sourced outside clinical compounding channels.
  • The only human RCT evidence on meniscal tears and conservative care, Katz et al. 2013 in the New England Journal of Medicine, found physical therapy alone comparable to surgery, meaning natural recovery with rehab is a highly plausible explanation for outcomes like Rahul's.
  • BPC-157 preclinical data in rodents shows real angiogenic and fibroblast-activating effects (Sikiric et al., 2018), but animal models have a poor track record of translating to human clinical outcomes, and no human trials for meniscal injuries exist.
  • TB-500's active component thymosin beta-4 has published anti-inflammatory and tissue-repair data in animal models (Goldstein et al., 2012), but systemic human recovery claims remain unsupported by controlled evidence.
  • Rahul used peptides during a period that included months of rest, gradual load progression, and reduced training volume, all known contributors to meniscal symptom improvement, making peptide attribution scientifically untenable from his story alone.
  • Buying injectable peptides from unregulated online sources, as Rahul describes doing after a Reddit search, carries real contamination and misdosing risks that his brief disclaimer does not adequately address.
  • Dull residual knee sensation after meniscal injury, which Rahul acknowledges still having, is consistent with incomplete healing or chronic irritation and suggests the peptides did not fully resolve the underlying structural issue.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @rahulmodifit actually say?

Rahul claims he tore his meniscus in late 2023 after aggressively chasing squat PRs, confirmed by ultrasound, and then used BPC-157 and TB-500 over roughly 18 weeks to avoid surgery. He says he returned to squatting 405 lbs by April 2024 and attributes his recovery to the peptides.

To his credit, he's upfront about the limits of his story. He says he's "not a physician," acknowledges his meniscus "doesn't fully heal," and admits going back to heavy squatting that fast probably wasn't smart. This is more honest than most peptide content on TikTok, where people present anecdote as proof. His mechanism descriptions, though simplified, aren't wildly off-base. But his central claim, that peptides helped him avoid surgery, is not something the current evidence can confirm or deny with any confidence.

Does the science back this up?

The honest answer: not robustly, not in humans, not for meniscus injuries specifically. Most BPC-157 research is rodent-based, and while some of it is genuinely interesting, animal models do not reliably translate to human clinical outcomes.

BPC-157 is a synthetic 15-amino-acid peptide derived from a protein found in gastric juice. Preclinical studies, including work by Sikiric et al. published repeatedly in Current Pharmaceutical Design and Journal of Physiology-Paris through the 2010s, show accelerated tendon and ligament healing in rats. The angiogenesis and fibroblast activation Rahul describes are supported in these models. TB-500, a synthetic fragment of thymosin beta-4, has similar preclinical data, with work by Goldstein and colleagues suggesting roles in actin regulation and tissue repair. But there are no published randomized controlled trials in humans for either peptide applied to meniscal injuries. Zero. When someone says peptides "healed" their meniscus, that claim has no clinical trial support. What we have is animal data, case reports, and a lot of Reddit.

What did they get wrong (or right)?

He got the basic mechanism description mostly right. BPC-157 does appear to stimulate angiogenesis and fibroblast activity in preclinical models. His description of TB-500 as working "more systemically" is a reasonable lay interpretation of how thymosin beta-4 fragments behave differently from more locally-acting peptides.

Where the video misleads, not through lying but through omission, is the attribution problem. Rahul injured his meniscus, rested for months, did light progressive loading, and also took peptides. Meniscus injuries, particularly partial tears, can improve significantly with conservative management alone. A 2013 study by Katz et al. in the New England Journal of Medicine found that physical therapy alone performed comparably to arthroscopic surgery for meniscal tears with osteoarthritis. The natural history of meniscal injuries, especially in a young, fit person doing controlled rehab, could account for most or all of his recovery. He cannot isolate the peptide effect from rest, rehabilitation, and time. That's not him being dishonest. That's just how anecdote works.

He also casually mentions buying peptides from Reddit research chemical sources, which are unregulated, unverified for purity, and not approved by the FDA for human use. That's a real safety issue that deserves more than a brief disclaimer.

What should you actually know?

BPC-157 and TB-500 are not FDA-approved for any human indication. They are sold as research chemicals, which means no guaranteed purity, no standardized preparation, and no regulatory oversight of what's actually in the vial. This matters a lot if you're injecting something.

Meniscal tear outcomes vary significantly by tear type, location, and patient age. Degenerative tears in active adults often respond well to conservative care, which typically means physical therapy, load management, and time. Rahul's outcome is plausible with or without peptides. The honest interpretation of his story is not "peptides healed my meniscus" but rather "I took peptides during a period of conservative recovery and I got better." Those are very different statements.

If you have a confirmed meniscal tear, an orthopedic surgeon and a sports medicine physician are the appropriate starting points, not a Reddit rabbit hole. Peptide research is evolving and some of it is legitimate science worth watching, but "interesting preclinical data" is not the same as "proven treatment."

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Rahul | Weight Loss Coach · TikTok creator

11.3K views on this video

How peptides helped me avoid knee surgery 💉🦵 In late 2023, I hit a 385 lb squat PR during a bulk — but I was pushing PRs every week like an idiot, and a week later, I tore my meniscus. It wasn’t during a lift, but the wear and tear had built up. I didn’t want surgery — it would’ve meant losing more of my meniscus, which doesn’t grow back. That’s when I turned to peptides: BPC-157 and TB-500. 🔬 How they work: • BPC-157 stimulates blood vessel growth, boosts nitric oxide, and activates fibr

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about neither bpc-157 nor tb-500?

Neither BPC-157 nor TB-500 is FDA-approved for human use, and both are classified as research chemicals with no guaranteed purity or sterility standards when sourced outside clinical compounding channels.

What does the video say about the only human rct evidence on meniscal tears?

The only human RCT evidence on meniscal tears and conservative care, Katz et al. 2013 in the New England Journal of Medicine, found physical therapy alone comparable to surgery, meaning natural recovery with rehab is a highly plausible explanation for outcomes like Rahul's.

What does the video say about bpc-157 preclinical data in rodents shows real angiogenic?

BPC-157 preclinical data in rodents shows real angiogenic and fibroblast-activating effects (Sikiric et al., 2018), but animal models have a poor track record of translating to human clinical outcomes, and no human trials for meniscal injuries exist.

What does the video say about tb-500's active component thymosin beta-4 has published anti-inflammatory?

TB-500's active component thymosin beta-4 has published anti-inflammatory and tissue-repair data in animal models (Goldstein et al., 2012), but systemic human recovery claims remain unsupported by controlled evidence.

What does the video say about rahul used peptides during a period?

Rahul used peptides during a period that included months of rest, gradual load progression, and reduced training volume, all known contributors to meniscal symptom improvement, making peptide attribution scientifically untenable from his story alone.

What does the video say about buying injectable peptides from unregulated online sources, as rahul describes?

Buying injectable peptides from unregulated online sources, as Rahul describes doing after a Reddit search, carries real contamination and misdosing risks that his brief disclaimer does not adequately address.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Rahul | Weight Loss Coach, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.